These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 26169974)

  • 1. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
    Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
    Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
    Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M;
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.
    Fernandes BS; Steiner J; Berk M; Molendijk ML; Gonzalez-Pinto A; Turck CW; Nardin P; Gonçalves CA
    Mol Psychiatry; 2015 Sep; 20(9):1108-19. PubMed ID: 25266124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
    Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India.
    Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B
    Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis.
    Wang Z; Li P; Chi D; Wu T; Mei Z; Cui G
    Oncotarget; 2017 Sep; 8(43):75445-75454. PubMed ID: 29088880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups.
    Joseph J; Depp C; Martin AS; Daly RE; Glorioso DK; Palmer BW; Jeste DV
    Schizophr Res; 2015 Oct; 168(1-2):456-60. PubMed ID: 26341579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients.
    Akanji AO; Ohaeri JU; Al-Shammri S; Fatania HR
    Psychiatry Res; 2009 Aug; 169(1):56-61. PubMed ID: 19619902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased high-sensitivity C-reactive protein levels in Taiwanese schizophrenic patients.
    Lin CC; Chang CM; Liu CY; Huang TL
    Asia Pac Psychiatry; 2013 Jun; 5(2):E58-63. PubMed ID: 23857813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.
    Fond G; Godin O; Boyer L; Berna F; Andrianarisoa M; Coulon N; Brunel L; Bulzacka E; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Schürhoff F; Leboyer M;
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):985-992. PubMed ID: 29808267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between brain damage, associated biomarkers, and medication in psychiatric inpatients: A cross-sectional study.
    Yoshida M; Kanzaki T; Mizoi M; Nakamura M; Uemura T; Mimori S; Uju Y; Sekine K; Ishii Y; Yoshimi T; Yasui R; Yasukawa A; Sato M; Okamoto S; Hisaoka T; Miura M; Kusanishi S; Murakami K; Nakano C; Mizuta Y; Mishima S; Hayakawa T; Tsukada K; Kashiwagi K; Igarashi K
    Clin Chim Acta; 2017 Jan; 464():50-56. PubMed ID: 27816667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.
    Fan X; Pristach C; Liu EY; Freudenreich O; Henderson DC; Goff DC
    Psychiatry Res; 2007 Jan; 149(1-3):267-71. PubMed ID: 17112596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.
    Steiner J; Frodl T; Schiltz K; Dobrowolny H; Jacobs R; Fernandes BS; Guest PC; Meyer-Lotz G; Borucki K; Bahn S; Bogerts B; Falkai P; Bernstein HG
    Schizophr Bull; 2020 Feb; 46(2):363-373. PubMed ID: 31504969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review.
    Fond G; Lançon C; Auquier P; Boyer L
    Front Psychiatry; 2018; 9():392. PubMed ID: 30190688
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives.
    Carrizo E; Fernández V; Quintero J; Connell L; Rodríguez Z; Mosquera M; Acosta A; Baptista T
    Schizophr Res; 2008 Aug; 103(1-3):83-93. PubMed ID: 18436434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.
    Bulzacka E; Boyer L; Schürhoff F; Godin O; Berna F; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chéreau-Boudet I; Chesnoy-Servanin G; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Roux P; Yazbek H; Leboyer M; Fond G;
    Schizophr Bull; 2016 Sep; 42(5):1290-302. PubMed ID: 27143795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid levels in subjects with schizophrenia: A systematic review and meta-analysis.
    He Q; You Y; Yu L; Yao L; Lu H; Zhou X; Wu S; Chen L; Chen Y; Zhao X
    Psychiatry Res; 2020 Oct; 292():113305. PubMed ID: 32702552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of high-sensitivity C-reactive protein with susceptibility to Schizophrenia in Tunisian population.
    Ayari F; Ben Chaaben A; Ben Ammar H; Nefzi R; Ouni N; Mihoub O; Abaza H; Aissa A; Douik H; Gara S; Larnaout A; Salmi A; Ben Ammar-El Gaaied A; Leboyer M; El Hechmi Z; Guemira F; Tamouza R
    Encephale; 2020 Aug; 46(4):241-247. PubMed ID: 31959465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses.
    Aas M; Dieset I; Hope S; Hoseth E; Mørch R; Reponen E; Steen NE; Laskemoen JF; Ueland T; Aukrust P; Agartz I; Andreassen OA; Melle I
    Brain Behav Immun; 2017 Oct; 65():342-349. PubMed ID: 28619247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.